EPIX (ESSA Pharma) Shiller PE Ratio: (As of Aug. 25, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

EPIX ESSA Pharma Inc EPIX
22 GF Score
Price $0.20
View Full Analysis

What is ESSA Pharma Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


ESSA Pharma  (NAS:EPIX) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


ESSA Pharma Shiller PE Ratio Related Terms


ESSA Pharma Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for ESSA Pharma's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ESSA Pharma Shiller PE Ratio Chart

ESSA Pharma Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

ESSA Pharma Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

EPIX vs SLXN, NLSP, PTNT: Shiller PE Ratio Comparison

For the Biotechnology subindustry, ESSA Pharma's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ESSA Pharma Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ESSA Pharma's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where ESSA Pharma's Shiller PE Ratio falls into.


EPIX
22GF Score
ESSA Pharma Inc EPIX
Shiller PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ESSA Pharma Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

ESSA Pharma's E10 for the quarter that ended in Jun. 2025 is calculated as:

For example, ESSA Pharma's adjusted earnings per share data for the three months ended in Jun. 2025 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2025 (Change)*Current CPI (Jun. 2025)
=-0.09/129.8920*129.8920
=-0.090

Current CPI (Jun. 2025) = 129.8920.

ESSA Pharma Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201509 1.400 100.421 1.811
201512 -3.600 99.947 -4.679
201603 -0.800 101.054 -1.028
201606 -2.600 102.002 -3.311
201609 -3.000 101.765 -3.829
201612 1.000 101.449 1.280
201703 -5.230 102.634 -6.619
201706 2.320 103.029 2.925
201709 -1.400 103.345 -1.760
201712 -1.440 103.345 -1.810
201803 -0.830 105.004 -1.027
201806 -0.500 105.557 -0.615
201809 -0.390 105.636 -0.480
201812 -0.430 105.399 -0.530
201903 -0.540 106.979 -0.656
201906 -0.520 107.690 -0.627
201909 -0.070 107.611 -0.084
201912 -0.220 107.769 -0.265
202003 -0.450 107.927 -0.542
202006 -0.240 108.401 -0.288
202009 -0.170 108.164 -0.204
202012 -0.200 108.559 -0.239
202103 -0.360 110.298 -0.424
202106 -0.210 111.720 -0.244
202109 -0.200 112.905 -0.230
202112 -0.210 113.774 -0.240
202203 -0.250 117.646 -0.276
202206 -0.200 120.806 -0.215
202209 -0.140 120.648 -0.151
202212 -0.150 120.964 -0.161
202303 -0.160 122.702 -0.169
202306 -0.170 124.203 -0.178
202309 -0.120 125.230 -0.124
202312 -0.140 125.072 -0.145
202403 -0.200 126.258 -0.206
202406 -0.160 127.522 -0.163
202409 -0.140 127.285 -0.143
202412 -0.190 127.364 -0.194
202503 -0.140 129.181 -0.141
202506 -0.090 129.892 -0.090

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


ESSA Pharma Business Description

Address 999 West Broadway Street, Suite 720, Vancouver, BC, CAN, V5Z 1K5
ESSA Pharma Inc is a pharmaceutical company. The company was focused on the development of small-molecule drugs for the treatment of castration-resistant prostate cancer. It was developing drugs that selectively block the amino-terminal domain of the androgen receptor, potentially overcoming the known AR-dependent resistance mechanisms of CRPC and providing CRPC patients with the potential for increased progression-free and overall survival. Currently, the company has terminated its clinical trials and other studies.
22GF Score

Get the complete analysis for EPIX

Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.20
Price